Abstract
Improved fermentation and isolation procedures for antitumor antimetabolites U-42,126 and U-43,795 increased drug yields 30-fold. The sensitivity limit of a newly developed assay is 0.03 μg of U-42,126 and 2.0 μg of U-43,795 per ml. The in vitro antimicrobial effect of both drugs was antagonized by histidine.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- HANKA L. J. Mechanism of action of psicofuranine. J Bacteriol. 1960 Jul;80:30–36. doi: 10.1128/jb.80.1.30-36.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hanka L. J., Dietz A. U-42, 126, a new antimetabolite antibiotic: production, biological activity, and taxonomy of the producing microorganism. Antimicrob Agents Chemother. 1973 Mar;3(3):425–431. doi: 10.1128/aac.3.3.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hanka L. J., Martin D. G., Neil G. L. A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. Cancer Chemother Rep. 1973 Apr;57(2):141–148. [PubMed] [Google Scholar]
- Martin D. G., Chidester C. G., Mizsak S. A., Duchamp D. J., Baczysnkyj L. The isolation, structure, and absolute configuration of U-43,795, a new antitumor agent. J Antibiot (Tokyo) 1975 Jan;28(1):91–93. doi: 10.7164/antibiotics.28.91. [DOI] [PubMed] [Google Scholar]
- Martin D. G., Hanka L. J., Neil G. L. A new antitumor agent, (alphas, 4s, 5r)-alpha-amino-3-chloro-4-hydroxy-4,5-dihydro-5-isoxazoleacetic acid (NSC-176324): preliminary evaluation against L 1210 mouse leukemia in vivo. Cancer Chemother Rep. 1974 Nov-Dec;58(6):935–937. [PubMed] [Google Scholar]